A special invitation: European Diabetic Eye Conference, Assembly Buildings, Belfast.

Thursday 26th – Saturday 28th May 2022

Prof. Tunde Peto, President of the European Association for Diabetic Eye Complications (EAsDEC) warmly invites NI Optometrists to register for this special event.

It is the only conference event in Europe centred on diabetic eye disease and thus attracts high calibre researcher and clinical practitioners from across this specialist area. This year the scientific programme will explore aspects of diabetic eye care both in clinical and research settings and will have direct clinical relevance to diabetic eye care in Northern Ireland. (See conference programme)

NIOS will sponsor a limited number of places for members to attend Thursday/ Friday afternoon, as well as Saturday morning, so please contact Sara Shields at sara.shields@qub.ac.uk to register.

Each morning/afternoon session is £25 per delegate. (NIOS will refund the educational sessions attended)

If you wish to attend the conference dinner on Friday evening 27th May 2022 at Crumlin Gaol, it is £50 per person.​

If you would like to register please contact Sara Shields at quoting NIOS – sara.shields@qub.ac.uk 

Programme:

Thursday, 26th May 2022
VENUE: Assembly building
https://www.presbyterianireland.org/Utility/About-Us/Assembly-Buildings.aspx

16:00 Registration
16.30 – 18.30: Symposium: Re-imaging the diabetic eye: from cameras to cost effectiveness
Chairs: Professors Simon Harding and Tunde Peto
16.30 -16.35: Professor Simon Harding: Introduction
16.35 – 16.50: T Peto, UK: Imaging the diabetic eye – current best practices and
pitfalls
16.50 – 17.05: P Silva, USA: Association of Predominantly Peripheral Lesions on
Ultrawide Field Imaging and the Risk of Diabetic Retinopathy Worsening Over Time:
Results from DRCR Retina Network Protocol AA
17.05 – 17.25: S Sadda, USA: Re-thinking diabetic eye disease severity scales
17.25 – 17.45: S Harding, UK: Adding cost to the equation: cost effectiveness of
diabetes eye care
17.45 – 18.05: A Tuulonen, Finland: How to think big when considering costs?
18.05 -18.20: P Huhtinen Finland: Game plan to implement screening – findings
after 15 years of experimenting
18.20 – 18.40: Discussion
18.40: Official opening of EAsDEC and the Annual Meeting Welcome Reception
VENUE: Assembly building: Fingerfood and soft drinks

 

FRIDAY, 27th MAY 2022

13.00 SESSION 3: POSTER SESSION

Diabetic Eye Screening: Moderated by Dr M Torm and Dr P Piyasena
R. Thomas (UK): INCIDENCE OF SIGHT AND SEVERE SIGHT IMPAIRMENT
CERTIFICATIONS FROM 2010 TO 2020 DUE TO DIABETIC RETINOPATHY IN
ENGLAND AND WALES
I. Marques (Portugal): CHARACTERIZATION OF TWO-YEAR PROGRESSION OF
CAPILLARY CLOSURE IN NONPROLIFERATIVE DIABETIC RETINOPATHY
E. McBride (Ireland): ADDRESSING TECHNICAL FAILURES IN A DIABETIC
RETINOPATHY SCREENING PROGRAMME
I.O.B.A. Laurencio, Spain: TELEOPHTHALMOLOGY DIABETIC RETINOPATHY
SCREENING PROGRAM IN CASTILLA Y LEóN
I. Brennan (Ireland): EVALUATING THE EFFICIENCY OF THE IRISH NATIONAL
DIABETIC RETINAL SCREENING SERVICE’S TREATMENT PATHWAY
A. Hamid (UK): FIVE-YEAR OUTCOMES OF DIABETIC EYE SCREENING IN
PATIENTS AGED 85 YEARS
L. Ribeiro (Portugal): CHARACTERISATION OF TWO-YEAR PROGRESSION OF
RISK PHENOTYPES OF DIABETIC RETINOPATHY

Clinical practice in diabetic eye: Dr M Cicinelli and Dr A R Santos
V.A. Biletskaya (Russia): ASSESSMENT OF PROLIFERATIVE DIABETIC
RETINOPATHY BIOMARKERS IN VITREOUS FLUID
J. Grauslund (Denmark): PRESENCE AND DEVELOPMENT OF DIABETIC
RETINOPATHY IN 153,238 PATIENTS WITH TYPE 2 DIABETES IN THE DANISH
REGISTRY OF DIABETIC RETINOPATHY
G. Weisner (UK): THE EFFECT OF DEFERRED INJECTION TREATMENT DUE
TO COVID-19 ON DISEASE ACTIVITY IN PATIENTS WITH DIABETIC MACULAR
OEDEMA
J. Perais (UK): PREDICTIVE FACTORS ASSOCIATED WITH ANATOMICAL AND
FUNCTIONAL OUTCOMES FOLLOWING PANRETINAL PHOTOCOAGULATION
IN PEOPLE WITH PROLIFERATIVE DIABETIC RETINOPATHY
K. Gooding (UK): EXAMINING WHETHER GROWTH DIFFERENTIATION
FACTOR-15 IS ALTERED IN THE EARLY STAGES OF DIABETIC RETINOPATHY
IN INDIVIDUALS WITH TYPE 2 DIABETES
L. Cushley (UK): INTEGRATING DIABETIC EYE SCREENING INTO REGIONAL
HAEMODIALYSIS UNITS, NORTHERN IRELAND
S. Kelly (Ireland): NON-ATTENDANCE RATES OF PATIENTS ATTENDING
TREATMENT CENTRES FOR DIABETIC RETINOPATHY IN IRELAND
I. Brennan (Ireland): EVALUATION OF EFFICIENCY OF THE TREATMENT
PATHWAY OF IRISH NATIONAL DIABETIC RETINAL SCREENING SERVICE

Laboratory and experimental studies: Moderated by K Little and H Ramos
J. Augustine (UK): EVALUATION OF 2-HYDRAZINO-4,6-DIMETHYLPYRIMIDINE
(2-HDP) AS A THERAPEUTIC FOR THE EARLY-STAGE TREATMENT OF
DIABETIC RETINOPATHY
A.I. Arroba (Spain): UNRAVELLING THE ANTI-OXIDATIVE EFFECTS OF A
BIOACTIVE MARINE MOLECULE DURING NEUROINFLAMMATION
ASSOCIATED WITH DIABETIC RETINOPATHY
P. Barabas (UK): INTRAVITREAL AAV2.COMP-ANG1 PREVENTS LOCAL
CAPILLARY BLOOD FLOW CHANGES IN THE DIABETIC MOUSE RETINA
S. Tarban (UK): TRANSCRIPTOMIC ANALYSIS OF BARRIER GENE
EXPRESSION IN HUMAN RETINAL MICROVASCULAR ENDOTHELIAL
CELLS(HRMECS) EXPOSED TO HYPERGLYCAEMIA AND VEGF
A. Rollo (UK): TARGETING TRP CHANNELS FOR THE RESTORATION OF
MICROVASCULAR BARRIER FUNCTION IN DIABETIC MACULAR OEDEMA
B.M. Karan (UK): GENE THERAPEUTIC ENHANCEMENT OF ACROLEIN
DETOXIFICATION MECHANISMS FOR THE TREATMENT OF DIABETIC
RETINOPATHY(DR)
E. Beli (UK): DISRUPTED RYTHMS IN THE DIABETIC RETINA: ARE THEY
CONTROLLED BY A BROKEN CLOCK?

Tea/coffee will be available throughout the poster session

2.30 – 3.15: EVA KOHNER Lecture: Professor Sobha Sivaprasad, Moorfields
Eye Hospital NHS Foundation Trust, London, UK
Introduced by Professor Tunde Peto, QUB, UK
3.20: SESSION 4: Clinical issues in diabetic eye care
Chaired by: Professor Stela Vujosevic and Dr Recivall Salongcay
3.20 – 3.45: N Lois, UK: DIABETIC MACULAR OEDEMA AND DIODE
SUBTHRESHOLD MICROPULSE LASER (DIAMONDS TRIAL)
3.45 – 3.59: M.V. Cicinelli, Italy: FLUCTUATIONS IN DIABETIC RETINOPATHY
SEVERITY: ASSOCIATED FACTORS AND PROGNOSTIC SIGNIFICANCE
3.59 – 4.11: J. Talks, UK: EVALUATION OF INTRAVITREAL AFLIBERCEPT
TREATMENT EFFECTIVENESS IN UK ROUTINE CLINICAL PRACTICE FOR
PATIENTS WITH DIABETIC MACULAR EDEMA: 24-MONTH OUTCOMES OF
THE DRAKO STUDY
4.11 – 4.23: T. Peto, UK: REAL-WORLD COHORT OF PATIENTS WITH DIABETIC
MACULAR OEDEMA FROM 4 UK NATIONAL HEALTH SERVICE TREATMENT
CENTRES
4.23 -4.35: McCullough, UK: OUTCOMES AND COMPLICATIONS OF PARS
PLANA VITRECTOMY FOR TRACTIONAL RETINAL DETACHMENTS IN
PEOPLE WITH DIABETES MELLITUS: A SYSTEMATIC REVIEW AND METAANALYSIS
4.40 – 5.15: Roundtable discussion: The ever expanding treatment choices for
DME – case presentations and treatment paradigm discussions
5.20: ANNUAL GENERAL MEETING
Moderator: Professor Stela Vujosevic
7.00 CONFERENCE DINNER
Location: Crumlin Road Gaol – truly an old gaol and can be cool inside, so please
have an extra layer of clothing with you just in case you need it!
https://visitbelfast.com/partners/crumlin-road-gaol/

SATURDAY, 28th MAY 2022

08.30 Registration
8.55 SESSION 6: Imaging the diabetic eye
Chaired by: Professors Reinier Schlingemann and Paolo Silva
9.00 – 09.12: K.L.R. Locaylocay, Philippines: UTILIZATION OF DILATED
SMARTPHONE FUNDUS IMAGING FOR SCREENING OF DIABETIC
RETINOPATHY IN AN URBAN COMMUNITY SETTING IN PASIG CITY,
PHILIPPINES
09.12 -09.24: K Curran, UK: UK BIOBANK RETINAL IMAGING GRADING:
METHODOLOGY, BASELINE CHARACTERISTICS AND FINDINGS FOR
COMMON OCULAR DISEASES
9.24 – 9.36: S. Vujosevic, Italy: MULTIMODAL RETINAL IMAGING AS
BIOMARKER FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH
DIABETES MELLITUS
9.36 – 9.48: R. Salongcay, Philippines, UK: RETINAL FIELDS NONPERFUSION
IDENTIFIED ON ULTRAWIDE FIELD FLUORESCEIN ANGIOGRAPHY IN
DIABETIC EYES
9.48 – 10.00: M. Torm, Denmark: MACULAR VASCULAR DENSITY IN CHILDREN
AND ADOLESCENTS WITH TYPE I DIABETES
10.00 – 10.12: Y. Meng, UK: DIAGNOSIS OF DIABETIC NEUROPATHY BY
ARTIFICIAL INTELLIGENCE USING CORNEAL CONFOCAL MICROSCOPY
10.15 -10.40: Mini-lecture: Dr Paolo Silva, Joslin Diabetes Centre, USA:
Association of Ultrawide Field Fluorescein Angiography-identified Retinal
Nonperfusion with Risk of Diabetic Retinopathy Worsening Over Time: Results from
DRCR Retina Network Protocol AA
10.40 – 11.05: Coffee/tea break
11.05 SESSION 7: Dual sensory loss and visual function
Moderators: Dr Ruth Hogg and Professor C Plack
11.05 – 11.20: Mr Brian Symington: Introduction to dual sensory loss: hearing
and visual loss
11.20-11.40: C.J Plack, UK: SUB-CLINICAL AUDITORY DEFICITS IN TYPE 1
DIABETES MELLITUES
11.40 – 11.52: R. Hogg, UK: INTERPRETABLE MACHINE LEARNING TO
IDENTIFY VISUAL FUNCTION MEASURES WHICH BEST DESCRIBE DIABETIC
RETINOPATHY STAGE
11.55 -12.05: Best poster prize ceremony
Presented by Professor Tunde Peto
12.05 – 12.55: Public lecture: Hosted by Professor Tunde Peto, QUB, UK
(Panel of speakers including Dr Kieran Walshe, Paolo Silva, Tunde Peto)
We thank the Welcome Trust for enabling this lecture.
12.55 – 13.00: Closing remarks – Professor Tunde Peto